sponsored partly by Chugai Pharmaceutical Co., Ltd.: Chugai; Research grant/Funding (self): Sanofi. M. Yanagita: Honoraria (self): Chugai; Honoraria (self): Kyowa Hakko Kirin; Research grant/Funding (institution): Kyowa Hakko Kirin; Research grant/Funding… Click to show full abstract
sponsored partly by Chugai Pharmaceutical Co., Ltd.: Chugai; Research grant/Funding (self): Sanofi. M. Yanagita: Honoraria (self): Chugai; Honoraria (self): Kyowa Hakko Kirin; Research grant/Funding (institution): Kyowa Hakko Kirin; Research grant/Funding (institution): Tanabe Mitsubishi; Research grant/ Funding (institution): Nippon Boehringer Ingelheim; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Baxter; Research grant/Funding (institution): Chugai; Research grant/Funding (institution): Kyowa Hakko Kirin; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Takeda. All other authors have declared no conflicts of interest.
               
Click one of the above tabs to view related content.